U.S. pharma giant copyright scrapped two experimental weight loss pills final year—a at the time-daily capsule, lotiglipron, as a consequence of elevated liver enzymes along with a twice-day-to-day capsule, danuglipron, as a consequence of potent Unintended effects—but CEO Albert Bou